CMAST to participate in the bio international convention (Boston, us - 4-7 june, 2018)


CMAST, a leading consultancy & project management company in life sciences, will participate in the 25th edition of the BIO International Convention (BIO), that will take place from June 4th-7th in Boston, US. BIO is the world’s largest biotech gathering; attracting 16,000+ biotechnology and pharma leaders who come together to discover new business opportunities and promising partnerships. Belgium will be one of the top delegations with 66 participating companies.

CMAST will present its activities at the Belgian Pavilion in the BIO Exhibition Hall (booth #1743), is available for meetings in the ONE on ONE Partnering tool, and will participate in the famous Belgian Café on Tuesday June 5th (7-11 PM) at THE HARP, 85 Causeway Street, Boston, USA (details).

Glenn Van Dael, CEO, and Karin Van den Eeden, Operations & Business Relations Manager, will represent CMAST at the conference.

The BIO International Convention is an organization of the Biotechnology Innovation Organization (BIO). and Flanders Investment & Trade coordinate the participation of Flemish companies to this major life sciences conference.


CMAST is a leading consultancy and project management company in life sciences.
With a team of more than 90 industry experts, CMAST provides support to pharma and life sciences companies, universities and research institutes.

The company offers consultancy, project management and tangible business solutions in the following areas:

  • Early stage innovation services
  • Funding services
  • Project & Portfolio Management
  • R&D process optimization
  • Multi-stakeholder collaborations
  • Regulatory compliance & quality
  • Health data analytics & visualization
  • Supply chain

CMAST is headquartered in Temse (Belgium) and has branches in Switzerland, Germany, Poland and the US. Since 2018 CMAST is part of The Adecco Group, which gives the company a global reach.



Interested in a regular update of the Life Sciences and biotech sector in Flanders?